Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07696338
NA

Rethinking Early Airway Clearence Therapies

Sponsor: Nicole Hamblett

View on ClinicalTrials.gov

Summary

The REACT trial consists of two parallel, randomized studies; the Hypertonic Saline Study and the Dornase Alfa Study. Health outcomes among people with cystic fibrosis (CF) have been steadily improving, most recently with the advent of highly effective modulator therapy (HEMT). While therapies like hypertonic saline (HS) and dornase alfa (DA) improved outcomes in the past, they are often burdensome. Now that almost 90% of the North American CF population is being treated with elexacaftor/tezacaftor/ivacaftor (ETI) or vanzacaftor/tezacaftor/deutivacaftor (VTD), this trial will evaluate whether these newer treatments make daily HS or DA unnecessary. The trial begins with a 6-week run-in period where participants continue ETI or VTD but stop using HS and DA. Eligible participants are then assigned to either the HS Study or the DA Study for one year. Within those groups, they are randomized to either daily use of HS or DA or as needed use only during respiratory illnesses. The study aims to find out if lung health is similar between children and teens taking HEMT who use HS or DA treatments daily and those who use HS or DA treatments only when they are sick.

Key Details

Gender

All

Age Range

3 Years - 16 Years

Study Type

INTERVENTIONAL

Enrollment

405

Start Date

2026-09-15

Completion Date

2030-02-28

Last Updated

2026-07-10

Healthy Volunteers

No

Interventions

OTHER

As-needed hypertonic saline (HS)

As-needed hypertonic saline (HS) therapy during the 52-week study period.

OTHER

Twice daily hypertonic saline (HS)

Twice daily hypertonic saline (HS) therapy during the 52-week study period. The concentration of HS is according to clinical prescription (e.g., 7% sodium chloride).

OTHER

As-needed dornase alfa (DA)

As-needed dornase alfa (DA) therapy during the 52-week study period.

OTHER

Daily dornase alfa (DA)

Daily dornase alfa (DA) during the 52-week study period.

Locations (39)

The Children's Hospital Alabama, University of Alabama at Birmingham

Birmingham, Alabama, United States

Tucson Cystic Fibrosis Center

Tucson, Arizona, United States

Childrens Hospital Los Angeles

Los Angeles, California, United States

CHOC Children's Hospital

Orange, California, United States

Stanford University Medical Center

Palo Alto, California, United States

Children's Hospital Colorado

Aurora, Colorado, United States

All Children's Hospital

St. Petersburg, Florida, United States

Children's Healthcare of Atlanta and Emory University

Atlanta, Georgia, United States

Ann & Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, United States

Riley Hospital for Children

Indianapolis, Indiana, United States

University of Iowa

Iowa City, Iowa, United States

John Hopkins Hospital

Baltimore, Maryland, United States

Boston Children's Hospital

Boston, Massachusetts, United States

University of Michigan, Michigan Medicine

Ann Arbor, Michigan, United States

Children's Hospitals and Clinics of Minnesota

Minneapolis, Minnesota, United States

The Minnesota Cystic Fibrosis Center

Minneapolis, Minnesota, United States

Children's Mercy Kansas City

Kansas City, Missouri, United States

St. Louis Children's Hospital

St Louis, Missouri, United States

University of Rochester Medical Center Strong Memorial

Rochester, New York, United States

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States

Rainbow Babies and Children's Hospital/University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States

Nationwide Children's Hospital

Columbus, Ohio, United States

Dayton Children's Hospital

Dayton, Ohio, United States

Oregon Health & Sciences University

Portland, Oregon, United States

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States

Children's Hospital of Pittsburgh of UPMC

Pittsburgh, Pennsylvania, United States

Medical University of South Carolina

Charleston, South Carolina, United States

University of Texas Southwestern / Children's Health

Dallas, Texas, United States

Baylor College of Medicine

Houston, Texas, United States

University of Virginia

Charlottesville, Virginia, United States

Virginia Commonwealth University

Richmond, Virginia, United States

Seattle Children's Hospital

Seattle, Washington, United States

Providence Medical Group, Cystic Fibrosis Clinic - Pediatrics

Spokane, Washington, United States

University of Wisconsin

Madison, Wisconsin, United States

Children's Wisconsin

Milwaukee, Wisconsin, United States

CF Centre BC Children's Hospital (Vancouver, Canada)

Vancouver, British Columbia, Canada

Queen Elizabeth II Hospital Halifax Adult CF Centre

Halifax, Nova Scotia, Canada

CF Centre Hospital for Sick Children (Toronto, ON)

Toronto, Ontario, Canada